InHealth is a privately owned, UK-basd company, that specialises in diagnostic services.
InHealth provides diagnostics and imaging services to the NHS and private hospitals and clinics, including MRI, CT, X-Ray, DXA, Nuclear Medicine, Mammography, Ultrasound, Interventional Cardiology, Audiology, ENT, Endoscopy and Physiological Measurement.
The company employs around 1,400 people, including clinical specialists and patient referral teams. Its services are provided from over 350 locations in the UK and Ireland and they work with a significant majority of NHS Trusts in the UK covering over 200 hospitals and over 80 community health clinics.
InHealth divides its business as 'Community' and 'Hospital'. In the community sector, the company has contracts with a large number of CCGs for direct access diagnostics following GP referral. Over the years the company has also been part of AQP contracts.
In the area of hospital trusts, InHealth has both mobile and fixed sites available. InHealth has a mobile fleet of over 55 fully mobile diagnostic scanners and a number of semi-permanent facilities. InHealth notes that this fleet can be mobilised quickly to fulfil or enhance existing diagnostic services and can be used for very short-term contracts.
In April 2017, InHealth reported the appointment of Geoff Searle to manage Integrated Services for the company signalling the company's strategy to improve its delivery of integrated services, i.e., building more multi-service locations.
InHealth’s business strategy has included acquiring existing diagnostic companies such as Preventicum and Vista Diagnostics. Some subsidiaries of the InHealth Group include, Molecular Imaging Solutions Ltd, Euroclinics UK Ltd, Preventicum UK Ltd, e-Locum Services Ltd, Vista Diagnostics Ltd and Prima Diagnostics.
Recent company acquisitions are Radiographer Reporting in January 2016, Pain Management Solutions in June 2016, and in September 2016, 76% of Health Intelligence. The acquisition on Pain Management Solutions will enhance InHealth's services in a community setting. In January 2017 InHealth acquired Care UK's Manchester CATS service.
InHealth also shows a great deal of interest in "bringing care closer to home"; it refers to "challenging the ststus quo" and disagreeing with clinicians in the acute sector in order to support more integrated community care.
The most recent accounts available for InHealth Ltd are for the financial year ending September 2016, for which the company reported revenue of £121.3 million (£128.3 million 2015). Operating profit was £5.9 million (£8.9 million 2015) and pre-tax profit was £5.9 million (almost £9 million 2015). This resulted in a profit of £4.3 million for the year to September 2016, compared to £6.4 million in 2015 financial year. InHealth paid just over £1.4 million in tax in the 2016 financial year, down from £2.3 million in the year to September 2015.
InHealth is a private company owned by The Damask Trust, the trustees of which are Ivan Bradbury and the Embleton Trust Corporation Ltd. (2016 Accounts via Companies House July 2017)
According to the company, InHealth has contracts with many major trusts and over the past 20 years has worked with all NHS trusts.
Recent contracts include new diagnostic services contracts across the country, including radiology contracts in Croydon, Kingston and Walsall and major breast screening contracts in Outer North-East London and Surrey.
The MRI contract in Kingston begun in November 2016 is valued at £35 million and is for 15 years. InHealth will provide a fully-managed MRI service for patients at Kingston Hospital.
In early 2016 InHealth was awarded a place on a framework for temporary and long term provision of mobile therapy units. Under this framework InHealth could provide mobile diagnostics.
An Adult ENT and Audiology Services contract awarded in May 2015 in Southampton was worth over £21 million.
Independent research organisation WeQ4U investigated call centre waiting times for a number of UK companies from various sectors. InHealth Netcare which is used by healthcare professionals to retrieve patients test results ranked as the worst company with delays of up to 74 minutes.
Other concerns of note
Questions have been raised over the extent to which preventive diagnostics, such as those carried out by InHealth’s subsidiary Preventicum, actually benefit patients with some arguing that in many cases they are unnecessary. Consumer group Which? has argued that some tests "are likely to cause more harm than good, some give widely inconsistent results and little useful information, and some detect disease when it's not really there.” They add that "false results cause worry, more investigations, and even unnecessary treatment - at a cost to the individual or the National Health Service”.